EUVIMEDEUVIMED entdecken
Crossref

ROS-scavenging nanomedicine for “multiple crosstalk” modulation in non-alcoholic fatty liver disease

Xiaofei Xin, Jingjing Li, Wantao Wu, Pengbo Zhao, Yang Yang, Ying Zhu, Lianjie Ren, Chao Qin, Lifang Yin

Biomaterials Science · 2023

DOI: 10.1039/d2bm02161g ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomaterials Science, 2023. Verfasst von Xiaofei Xin und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutics, China Pharmaceutical University, Nanjing, China. nada77@163.com. Hauptthemen laut MEDLINE: Non-alcoholic Fatty Liver Disease, Insulin Resistance. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 48 Literaturangaben. Gefördert von: National College Students Innovation and Entrepreneurship Training Program, Natural Science Foundation of Jiangsu Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Liver-targeted ROS-scavenging liposomes loaded with oridonin and LY294002 (RLLs) was developed and modulated the “multiple crosstalk” in NAFLD via targeting PI3K–AKT–mTOR–NF-κB signaling.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Non-alcoholic Fatty Liver DiseaseInsulin ResistanceMiceAnimalsReactive Oxygen SpeciesAntioxidantsNanomedicinePhosphatidylinositol 3-KinasesTissue DistributionLiverOxidative StressInsulinDiterpenes, Kaurane

Substanzen

Reactive Oxygen SpeciesAntioxidantsPhosphatidylinositol 3-KinasesInsulinoridoninDiterpenes, Kaurane

Autor:innen und Institutionen

  • Department of Pharmaceutics, China Pharmaceutical University, Nanjing, China. nada77@163.com.
  • NMPA Key Laboratory for Research and Evaluation of Pharmaceutical Preparations and Excipients, China Pharmaceutical University, Nanjing, China.
  • Center for Drug Evaluation, National Medical Products Administration, Beijing, China.
  • Key Laboratory of Drug Quality Control and Pharmacovigilance, China Pharmaceutical University, Nanjing, China.
  • State Key Laboratory of Natural Medicine, China Pharmaceutical University, Nanjing, China.

Förderung

  • National College Students Innovation and Entrepreneurship Training Program
  • Natural Science Foundation of Jiangsu Province

Zitieren

APA

Xin, X., Li, J., Wu, W., Zhao, P., Yang, Y., Zhu, Y., Ren, L., Qin, C., & Yin, L. (2023). ROS-scavenging nanomedicine for “multiple crosstalk” modulation in non-alcoholic fatty liver disease. Biomaterials Science. https://doi.org/10.1039/d2bm02161g

Vancouver

Xin X, Li J, Wu W, Zhao P, Yang Y, Zhu Y, et al. ROS-scavenging nanomedicine for “multiple crosstalk” modulation in non-alcoholic fatty liver disease. Biomaterials Science. 2023. doi:10.1039/d2bm02161g

BibTeX
@article{Xin2023,
  author = {Xin, Xiaofei and Li, Jingjing and Wu, Wantao and Zhao, Pengbo and Yang, Yang and Zhu, Ying and Ren, Lianjie and Qin, Chao and Yin, Lifang},
  title = {ROS-scavenging nanomedicine for “multiple crosstalk” modulation in non-alcoholic fatty liver disease},
  journal = {Biomaterials Science},
  year = {2023},
  doi = {10.1039/d2bm02161g}
}
Kostenlos starten →